Search research articles
Contact Us
Filters
Showing results (391-400 of 408) with videos related to
Page
of 41
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
September 12, 2022
Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention
Tsung-Ying Tsai, Hsin-Bang Leu, Pai-Feng Hsu, et al.
Respiratory Research
|
March 24, 2024
Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters
Yuan-Ting Hsu, Chao-Chien Wu, Chin-Chou Wang, et al.
Journal of the Chinese Medical Association : JCMA
|
October 10, 2023
Sex and age differences of major cardiovascular events in patients after percutaneous coronary intervention
Ya-Ling Yang, Su-Chan Chen, Cheng-Hsueh Wu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 15, 2021
Optimal blood pressure for patients with end-stage renal disease following coronary interventions
Ya-Ling Yang, Su-Chan Chen, Cheng-Hsueh Wu, et al.
The American Journal of Cardiology
|
December 11, 2012
Permanent pacemaker implantation for late atrioventricular block in patients receiving catheter ablation for atrioventricular nodal reentrant tachycardia
Jo-Nan Liao, Yu-Feng Hu, Tsu-Juey Wu, et al.
European Journal of Clinical Investigation
|
April 16, 2020
Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease
Ya-Ling Yang, Cheng-Hsueh Wu, Pai-Feng Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 11, 2020
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
James Chih-Hsin Yang, D Ross Camidge, Cheng-Ta Yang, et al.
Therapeutic Advances in Medical Oncology
|
June 7, 2021
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 23, 2019
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
Yi-Heng Li, Jaw-Wen Chen, Tsung-Hsien Lin, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 408) with videos related to
Sort By:
Page
of 41
Journal of Clinical Hypertension (Greenwich, Conn.)
|
September 12, 2022
Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention
Tsung-Ying Tsai, Hsin-Bang Leu, Pai-Feng Hsu, et al.
Respiratory Research
|
March 24, 2024
Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters
Yuan-Ting Hsu, Chao-Chien Wu, Chin-Chou Wang, et al.
Journal of the Chinese Medical Association : JCMA
|
October 10, 2023
Sex and age differences of major cardiovascular events in patients after percutaneous coronary intervention
Ya-Ling Yang, Su-Chan Chen, Cheng-Hsueh Wu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 15, 2021
Optimal blood pressure for patients with end-stage renal disease following coronary interventions
Ya-Ling Yang, Su-Chan Chen, Cheng-Hsueh Wu, et al.
The American Journal of Cardiology
|
December 11, 2012
Permanent pacemaker implantation for late atrioventricular block in patients receiving catheter ablation for atrioventricular nodal reentrant tachycardia
Jo-Nan Liao, Yu-Feng Hu, Tsu-Juey Wu, et al.
European Journal of Clinical Investigation
|
April 16, 2020
Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease
Ya-Ling Yang, Cheng-Hsueh Wu, Pai-Feng Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 11, 2020
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
James Chih-Hsin Yang, D Ross Camidge, Cheng-Ta Yang, et al.
Therapeutic Advances in Medical Oncology
|
June 7, 2021
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 23, 2019
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
Yi-Heng Li, Jaw-Wen Chen, Tsung-Hsien Lin, et al.
Page
of 41